She was aged 45, Bosnian, and had carried the kind of childhood trauma most of us will only ever read about, the war, endured young, folded silently into an adult life in London.
Over five years, I watched her accumulate a pharmacy's worth of prescriptions. Sleeping tablets. Antidepressants. Neuropathic pain relief. Onward referrals to MSK, to physio; to whichever clinician might finally have the answer. Every professional who saw her did what they had been trained to do. And still, nothing shifted.
It was in the smaller conversations, the ones you can only have when you have known a woman for years across the counter – in a language of trust rather than a language of clinic – that the picture began to form. She was not treatment resistant. She was perimenopausal. Trauma had almost certainly brought it forward.
I referred her back with a clear clinical case. She was initiated on HRT. Within five months she had come off the majority of her other medicines, and she was in a mental state she had not known in years.
She was one woman. But she is not one woman. She is a pattern.
I could tell this story a hundred times over, and I know I am not the only pharmacist who could. Women like her have been walking into our pharmacies for decades.
The question is not whether they are there. The question is whether we, as a profession, are ready to see them.
The gap we keep stepping around
Menopause is having its moment. Podcasts, panels, headlines, a growing cultural fluency that would have been unthinkable 10 years ago. And yet the women in front of me, the ones I have known for 15 or 20 years, the ones who trust me enough to ask about their teenage daughter's acne and their own bladder in the same breath, still tell me they feel unheard.
They are not imagining it. NICE NG23 provides a clear framework for menopause diagnosis and management, and the British Menopause Society continues to expand accessible, high-quality guidance for prescribers. But guidance is only ever as good as the profession that implements it. And too many women, especially those outside the traditional aged 45-to-55 white British demographic, are still slipping through the net.
This is not a GP failing. GPs are stretched, appointments are 10 minutes long, and menopause rarely presents itself neatly. This is a systems failing. And pharmacy, with its 60% female workforce and its unrivalled community access, is uniquely placed to close the gap.
If you are an independent prescriber and you are not yet delivering menopause care, ask yourself honestly: what are you waiting for?
Why pharmacists can step forward
Let me put this plainly. Other professionals ask us for advice on medicines. We know what we know. We are the experts in pharmacology, in interactions, in titration; in the small clinical decisions that make HRT the right medicine at the right dose for the right woman.
Why, then, are we still deferring the entire conversation to someone else?
The pipeline of independent prescribers has never been stronger. Newly qualified pharmacists are stepping into IP training as part of their foundation year. Established pharmacists have routes into prescribing that did not exist when I was training. The scope is there. The regulatory framework; GPhC, MHRA guidance on HRT products; the BNF are there.
What is missing, too often, is the confidence to say: this is our work.
Pharmacists should be the first profession a woman asks about her symptoms, not the last stop on a frustrating referral chain.
Our role is not to replace the GP. It is to work in synergy: to be the accessible, in-person, no-appointment-needed clinician who catches what a 10-minute GP slot cannot.
Know the woman in front of you
Here is what I have learned across three decades: menopause does not read the textbook, and it does not respect the demographics we were taught to expect it in.
For South Asian and African women, perimenopause can begin up to five years earlier than the average white British age range. That means we should be alert to symptoms in women in their late 30s and early 40s, not dismissing them as "too young”.
For women who have lived through refugee experience, sustained trauma, or the chronic activation of fight-and-flight, perimenopause can arrive earlier still. Deprivation shortens the runway too.
This is not a South Asian issue or an African issue or a refugee issue. It cuts across every sociodemographic and geographical cohort, and every community pharmacy in the country has these women on its books. You have them on yours. The question is whether you are looking for them.
We do not even always have a word for menopause in the languages our patients speak. That linguistic silence becomes a clinical silence. Women present with what they can name: a frozen shoulder, plantar fasciitis, poor sleep, anxiety, a brain fog they call "getting old," because the vocabulary for what is actually happening has never been offered to them.
Look at your patient cohort. You have known these women for years. You have counselled them through pregnancies, dispensed medicines to their parents, watched their children grow. You are already trusted. Now bring the clinical curiosity to match that trust.
Have the confidence to dig deeper. Ask the second question. Articulate with clinical precision what you are noticing, and why it matters.
We are more than qualified to design services that reflect the women we serve, and I would argue we have a responsibility to
The signs we should all be looking for
The classic vasomotor symptoms, hot flushes, night sweats are only the tip. The presentations that too often go unrecognised include:
- Frozen shoulder or adhesive capsulitis, particularly in women aged 40-55
- Plantar fasciitis and other unexplained musculoskeletal complaints
- Sleep disturbance that predates any obvious mood change
- Anxiety and low mood in women with no prior mental health history
- Brain fog, word-finding difficulty; cognitive drag
- Palpitations, dizziness; non-cardiac chest tightness
- Weight redistribution and stubborn central weight gain
- Recurrent UTIs, vaginal dryness, and genitourinary symptoms, often not raised until asked.
Every one of these women is already in your pharmacy. She is buying ibuprofen for the shoulder; sleep aids at the counter; HRT-free supplements marketed at her on TikTok. She needs a qualified clinician to ask the right question.
The weight gain conversation nobody wants to have
Middle-aged women lose their voice in medicine around weight. I hear it in my clinic every day. She has tried everything. She is walking 10,000 steps. She is eating less than her husband. Nothing shifts. Her self-esteem is on the floor.
The clinical picture is more nuanced than "eat less, move more". Perimenopausal weight gain reflects real physiological shifts, declining oestrogen, insulin resistance, sarcopenia, cortisol dysregulation. HRT is not a weight-loss medicine, but appropriate hormonal support can restore metabolic stability, sleep, and the capacity to actually respond to lifestyle interventions. Where GLP-1 therapy is clinically indicated, that is a separate and careful conversation, with full BMI, comorbidity, and MHRA prescribing considerations in view.
The question for us as pharmacists is not always "do I prescribe?" It is "am I the clinician who can help her think this through?" Often, we are and we should stop apologising for saying so.
For South Asian and African women, perimenopause can begin up to five years earlier than the average white British age range. Kam, if there is space to fill, this could be developed into a text box if needed. I’d rather not, but could.
Female entrepreneurship, rooted in sewa
I run my clinic in London’s Victoria under a simple philosophy: Science with Soul. Rooted in sewa, the Sikh principle of selfless service, that has anchored every decision in my career.
This means I do not always charge for the initial conversation. It means I have built a service on trust and loyalty rather than transaction. It means I am willing to say to a woman: “I do not think this is the right medicine for you yet; let's watch, review, and come back in eight weeks.”
This is what female entrepreneurship in pharmacy looks like. Sixty per cent of our profession is female. We are more than qualified to design services that reflect the women we serve, and I would argue we have a responsibility to.
You do not need a private clinic to do this. You need your IP qualification, your NICE guidelines open on your desktop, and the willingness to say: “I see her, and I am the clinician who can help”.
A call to my profession
If you are an independent prescriber and you are not yet delivering menopause care, ask yourself honestly: what are you waiting for?
The women are already in your pharmacy. The regulatory scope exists. The guidance is published. The training pathways, BMS-accredited menopause modules, RCGP resources adaptable for pharmacy, peer mentorship through the National Pharmacy Association, are more accessible than ever.
What is required now is the confidence to expand your scope of practice into what your community genuinely needs.
Pharmacy has an extraordinary opportunity in this decade to redefine what accessible women's healthcare looks like in the UK. If we do not take it, someone else will. And she will still be waiting.
